XML 36 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Segment and Geographic Information | 12 Months Ended
--- | ---
Dec. 31, 2017
Segment and Geographic Information [Abstract] |
Segment and Geographic Information | 1 5. SEGMENT AND GEOGRAPHIC INFORMATION The Company evaluates reporting segments in accordance with FASB ASC 280, “Segment Reporting”. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. These devices are developed and marketed to a broad base of medical centers globally. Management considers all such sales to be part of a single operating segment. Revenue attributed to geographic areas is based on the location of the customers to whom products are sold. Revenue by geographic area was as follows: ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |
﻿ |  | 2017 |  | 2016 |  | 2015
﻿United States |  | $ | 138,387 |  | $ | 122,385 |  | $ | 102,212
﻿Europe |  |  | 21,901 |  |  | 19,772 |  |  | 17,180
﻿Asia |  |  | 13,616 |  |  | 12,223 |  |  | 9,510
﻿Other international |  |  | 812 |  |  | 729 |  |  | 853
﻿Total international |  |  | 36,329 |  |  | 32,724 |  |  | 27,543
﻿Total revenue |  | $ | 174,716 |  | $ | 155,109 |  | $ | 129,755
﻿ United States revenue by product type was as follows: ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |
﻿ |  | 2017 |  | 2016 |  | 2015
﻿Open-heart ablation |  | $ | 64,517 |  | $ | 58,050 |  | $ | 53,541
﻿Minimally invasive ablation |  |  | 34,421 |  |  | 31,169 |  |  | 21,564
﻿AtriClip devices |  |  | 37,281 |  |  | 30,321 |  |  | 24,377
﻿Total ablation and AtriClip devices |  |  | 136,219 |  |  | 119,540 |  |  | 99,482
﻿Valve tools |  |  | 2,168 |  |  | 2,845 |  |  | 2,730
﻿Total United States |  | $ | 138,387 |  | $ | 122,385 |  | $ | 102,212
﻿ International revenue by product type was as follows: ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |
﻿ |  | 2017 |  | 2016 |  | 2015
﻿Open-heart ablation |  | $ | 20,718 |  | $ | 20,189 |  | $ | 16,287
﻿Minimally invasive ablation |  |  | 8,007 |  |  | 8,065 |  |  | 7,964
﻿AtriClip devices |  |  | 7,251 |  |  | 3,986 |  |  | 2,868
﻿Total ablation and AtriClip devices |  |  | 35,976 |  |  | 32,240 |  |  | 27,119
﻿Valve tools |  |  | 353 |  |  | 484 |  |  | 424
﻿Total international |  | $ | 36,329 |  | $ | 32,724 |  | $ | 27,543
﻿ The Company’s long-lived assets are located primarily in the United States, except for $957 as of December 31, 2017 and $931 as of December 31, 2016, which are located primarily in Europe.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration